B12 is a cofactor for the enzyme that converts methylmalonyl-CoA to succinyl-CoA
None of this handling detail changes the evidence question
According to UCLA Health, semaglutide was the first drug approved since 2014 specifically for chronic weight management in the majority of American adults who are classified as overweight or obese, yet insurance treatment of that weight-loss indication still lags well behind how insurers treat the diabetes indication for the same molecule
Pharmacy and state-availability records were last verified July 7, 2026
If semaglutide is exposed to extreme temperatures (which is above 86F (30C)), its stability and effectiveness can be harmed, leading to the diminishing of its therapeutic benefits
This includes discovery and pretrial motions regarding general causation evidence about the link between Ozempic and ileus, gastroparesis and other injuries, as well as questions about whether the claims are preempted by federal law and whether plaintiffs will be required to provide specific testing evidence to establish they suffered an injury